Respiratory Coronavirus – Page 6 – Communicable Diseases Research

Comparative genomic analysis reveals varying levels of mammalian adaptation to coronavirus infections

비교 게놈 분석은 코로나 바이러스 감염에 대한 다양한 수준의 포유류 적응을 보여줍니다.

Comparative Study

Published on 2021-11-182022-09-10
Journal: PLoS Computational Biology [Category] MERS, SARS, 바이오마커, 유전자 메커니즘,

Electroceutical fabric lowers zeta potential and eradicates coronavirus infectivity upon contact

Article

Published on 2021-11-052022-10-04
Journal: Scientific Reports [Category] MERS, SARS, 유전자 메커니즘,

[키워드] aggregation Antimicrobials Cell comparable Contact coronavirus COVID-19 Cytopathic effect disrupt Hypothesis Lower Microbiology MTT Particle PPE provide Respiratory Coronavirus significantly spread of COVID-19 tested Testing viability virion Virology virus
[DOI] 10.1038/s41598-021-00910-6 PMC 바로가기 [Article Type] Article

First direct human-to-cat transmission of the SARS-CoV-2 B.1.1.7 variant

SARS-CoV-2 B.1.1.7 변종의 첫 인간-고양이 직접 전파

Article

Published on 2021-11-012022-09-11
Journal: Australian veterinary journal [Category] SARS, 변종,

Multiple Sclerosis Following SARS-CoV-2 Infection: A Case Report and Literature Review

Neurology

Published on 2021-10-252022-10-31
Journal: Cureus [Category] COVID-19,

Evaluation of a multisectoral intervention to mitigate the risk of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission in long-term care facilities

장기 요양 시설에서 중증 급성 호흡기 코로나바이러스 2(SARS-CoV-2) 전파 위험을 완화하기 위한 다분야 개입 평가

Article

Published on 2021-10-012022-09-11
Journal: Infection Control and Hospital Epidemiology [Category] SARS, 치료기술,

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial

청소년 및 노인의 SARS-COV-2 재조합 스파이크 단백질 백신 (NVX-COV2373)의 상이한 용량 요법 : 2 상 무작위 위약 대조 시험

Clinical Trial

Published on 2021-10-012022-08-13
Journal: PLoS Medicine [Category] Biochemistry, MERS, SARS, 임상, 진단,

[키워드] 95% CI 95% confidence interval accumulate addition Administered Adults adverse events age Anti-spike Antibody Response assessments assigned composed conducted convalescent sera coronavirus Day dose dose regimen Efficacy Endpoint Enrollment exceeded Follow-up Formica Frequency full-length SARS-CoV-2 geometric mean geometric mean titer geometric mean titers GMTs group groups identify IgG immune persistence immune response immune responses immunogenic immunogenicity Immunoglobulin Immunoglobulin G include inhibitory concentration intensity intramuscular dose lack limitation Matrix-M1 adjuvant median Mild mild to moderate moderate neutralizing antibody Neutralizing antibody response neutralizing antibody responses NVX-CoV2373 occurred less Older Older adults participant Participants Phase 1 Phase 2 Placebo placebo-controlled placebo-controlled trial primary endpoints Protein Randomized randomized placebo-controlled trial Randomly reactogenicity receive Recombinant spike protein regimen researcher respiratory Respiratory Coronavirus robust safety follow-up SARS-CoV-2 second dose second vaccination secondary endpoint seroconversion rate seroconversion rates severity short duration spike glycoprotein spike glycoproteins Spike protein Support The United States These data Tolerability Treatment Trial Trial registration trimeric United States USA vaccination Vaccine vaccine group wild-type virus
[DOI] 10.1371/journal.pmed.1003769 PMC 바로가기 [Article Type] Clinical Trial

Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California

COVID-19 대유행 기간 동안 자궁경부암 검진 서비스 우선순위: 캘리포니아 대학 의료 센터 및 공공 안전망 병원의 대응

Article

Published on 2021-10-012022-09-11
Journal: Preventive medicine [Category] SARS, 치료기술,

Perception of Parents Towards COVID-19 Vaccine for Children in Saudi Population

Family/General Practice

Published on 2021-09-282022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] acceptability addition age approved caused children clinics collected complications contagious COVID-19 COVID-19 infection COVID-19 vaccine cross-sectional demographics disease Evidence Factors female Gender group healthcare include information lack likelihood majority male offer Older pandemic parent parental parents participant pediatric Perception Population primary care question questionnaire Respiratory Coronavirus Result SARS-CoV-2 Saudi Arabia Seasonal influenza significantly Spread statistically significant the disease the vaccine vaccinate vaccination Vaccine
[DOI] 10.7759/cureus.18342 PMC 바로가기 [Article Type] Family/General Practice

Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1

423

Published on 2021-09-142022-10-29
Journal: Proceedings of the National Academy of Sciences of [Category] COVID-19, SARS,

[키워드] addressed antiviral role Bioinformatics analysis catalytic activity caused Cell cleavage cleave cleaved complex conserved coronavirus Coronavirus replication COVID-19 decrease Degradation develop drug ENhance enzyme Evidence evidenced facilitate Factors finger global public health Host host antiviral response host protein identify inhibitor interferon interferon-stimulated gene ISGs knockdown M pro mutant nsp5 polyprotein Prevent promote protease provided Respiratory Coronavirus Ring risk RNA interference RNF20 RNF40 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 main protease SARS-CoV-2 replication Significance significantly SREBP1 stimulatory target treat viral replication
[DOI] 10.1073/pnas.2107108118 PMC 바로가기 [Article Type] 423

Testosterone in COVID-19: An Adversary Bane or Comrade Boon

Cellular and Infection Microbiology

Published on 2021-09-082022-10-31
Journal: Frontiers in Cellular and Infection Microbiology [Category] COVID-19, MERS, SARS,